ResultsIQ › Latest results › Health X Platform Limited
Health X Platform Limited Q3 FY26 results deck summary
NSE: HEALTHX · BSE: 533259
Results deck of 6 Feb 2026, summarised by AI from the filing.
Q3 FY26 revenue ₹341.3 cr (+22.0% YoY), PAT ₹0.4 cr vs ₹(40.0) cr loss; management targets 30%+ growth CAGR over next 5 years.
Key takeaways
- Q3 FY26 revenue Revenue from operations ₹341.3 cr (Q3 FY25: ₹279.8 cr, +22.0%; Q2 FY26: ₹307.9 cr, +10.8%)
- Growth target Management targets growth CAGR 30%+ over next 5 years
- PAT turnaround PAT ₹0.4 cr in Q3 FY26 vs ₹(40.0) cr in Q3 FY25 and ₹(15.4) cr in Q2 FY26
- SastaSundar growth SastaSundar revenue ₹43.3 cr in Q3 FY26 vs ₹17.6 cr in Q3 FY25
- EBITDA loss EBITDA ₹(14.8) cr in Q3 FY26, EBITDA margin (4.3%)
Health X Platform Limited Q1 FY27 results
As filed: Revenue ₹447 cr, EBITDA −₹8.4 cr, PAT ₹2.0 cr, EBITDA margin -1.9%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹447 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹374 cr, EBITDA −₹25.2 cr, PAT −₹13.0 cr, EBITDA margin -6.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹374 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +3.6% in 30 days (Nifty 500: +1.5%).
Past price moves after results do not indicate future moves. Not a recommendation.
Health X Platform Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (11 Aug 2026), Results deck (7 Aug 2026)
- Q4 FY26: Earnings call (12 Jun 2026), Results deck (1 Jun 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (6 Feb 2026), Results deck (6 Feb 2026)
- Q2 FY26: Earnings call (17 Nov 2025), Results deck (13 Nov 2025)
- Q1 FY26: Results deck (16 Aug 2025)
- Q4 FY25: Earnings call (12 Jun 2025), Results deck (2 Jun 2025)
- Other events: Strategy deck (10 Jun 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.